Quốc gia: Vương quốc Anh
Ngôn ngữ: Tiếng Anh
Nguồn: VMD (Veterinary Medicines Directorate)
Feline calicivirus, Feline panleukopenia virus, Feline viral rhinotracheitis virus
Boehringer Ingelheim Vetmedica Gmbh
QI06AH09
Feline calicivirus, Feline panleukopenia virus, Feline viral rhinotracheitis virus
Powder and solvent for suspension for injection
POM-V - Prescription Only Medicine – Veterinarian
Cats
Live and Inactivated Viral Vaccine
Authorized
2005-02-23
Revised: March 2023 AN: 01446/2022 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Purevax RCP lyophilisate and solvent for suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of 1 ml or 0.5 ml: Lyophilisate: ACTIVE SUBSTANCES: Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain) .............. 10 4.9 CCID 50 1 Inactivated feline calicivirus (FCV 431 and G1 strains) antigens........... 2.0 ELISA U. Attenuated feline panleucopenia virus (PLI IV) .................................... 10 3.5 CCID 50 1 EXCIPIENT: Gentamicin, at most ...........................................................................................16.5 µg Solvent: Water for injections ............................................................................q.s. 1 ml or 0.5 ml 1 cell culture infective dose 50%. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Lyophilisate and solvent for suspension for injection. Lyophilisate: homogeneous beige pellet. Solvent: clear colourless liquid. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Active immunisation of cats aged 8 weeks and older: - against feline viral rhinotracheitis to reduce clinical signs, - against calicivirus infection to reduce clinical signs, - against feline panleucopenia to prevent mortality and clinical signs. Onset of immunity: 1 week after primary vaccination course. Duration of immunity: 1 year after the primary vaccination course and 3 years after the last re-vaccination. Revised: March 2023 AN: 01446/2022 Page 2 of 5 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Vaccinate healthy animals only. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals None. Special precautions to be taken by the person administering the veterinary medicinal product to animals In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the la Đọc toàn bộ tài liệu